SIMILAR PATTERNS OF AMINO ACIDS FOR 5KR1_B_017B101_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1aug PYROGLUTAMYL
PEPTIDASE-1


(Bacillus
amyloliquefaciens)
PF01470
(Peptidase_C15)
5 LEU A   7
ALA A 200
ILE A 126
VAL A  69
ILE A  67
None
0.94A 5kr1A-1augA:
undetectable
5kr1A-1augA:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1b65 PROTEIN
(AMINOPEPTIDASE)


(Ochrobactrum
anthropi)
PF03576
(Peptidase_S58)
5 ARG A 222
ALA A 149
ASP A 147
GLY A 347
ILE A 187
None
1.01A 5kr1A-1b65A:
undetectable
5kr1A-1b65A:
13.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1d0b INTERNALIN B

(Listeria
monocytogenes)
PF12354
(Internalin_N)
PF12799
(LRR_4)
5 LEU A 110
ASN A 108
ILE A  82
VAL A  91
ILE A  88
None
1.00A 5kr1A-1d0bA:
undetectable
5kr1A-1d0bA:
17.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dby CHLOROPLAST
THIOREDOXIN M CH2


(Chlamydomonas
reinhardtii)
PF00085
(Thioredoxin)
5 LEU A  57
ILE A  37
GLY A  91
ILE A  90
VAL A  24
None
0.99A 5kr1A-1dbyA:
undetectable
5kr1A-1dbyA:
23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e6y METHYL-COENZYME M
REDUCTASE I BETA
SUBUNIT


(Methanosarcina
barkeri)
PF02241
(MCR_beta)
PF02783
(MCR_beta_N)
5 LEU B2249
GLY B2263
ILE B2262
VAL B2253
ILE B2252
None
0.99A 5kr1A-1e6yB:
undetectable
5kr1A-1e6yB:
14.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gm5 RECG

(Thermotoga
maritima)
PF00270
(DEAD)
PF00271
(Helicase_C)
PF17190
(RecG_N)
PF17191
(RecG_wedge)
5 LEU A 491
ASP A 412
ILE A 380
ILE A 496
VAL A 517
None
1.07A 5kr1A-1gm5A:
undetectable
5kr1A-1gm5A:
8.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
A79  A 800 ( 3.8A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
0.78A 5kr1A-1hvcA:
13.8
5kr1A-1hvcA:
44.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
VAL A  82
A79  A 800 ( 4.0A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 (-4.5A)
0.76A 5kr1A-1hvcA:
13.8
5kr1A-1hvcA:
44.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  30
ILE A  47
GLY A  49
ILE A  50
VAL A  82
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.60A 5kr1A-1hvcA:
13.8
5kr1A-1hvcA:
44.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  30
ILE A  47
GLY A  49
ILE A  50
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 ( 4.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.57A 5kr1A-1hvcA:
13.8
5kr1A-1hvcA:
44.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hyl HYPODERMA LINEATUM
COLLAGENASE


(Hypoderma
lineatum)
PF00089
(Trypsin)
5 LEU A 209
ALA A 136
GLY A 183
VAL A 231
ILE A 210
None
1.06A 5kr1A-1hylA:
undetectable
5kr1A-1hylA:
19.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jfl ASPARTATE RACEMASE

(Pyrococcus
horikoshii)
PF01177
(Asp_Glu_race)
5 ALA A  85
ILE A  45
GLY A   8
ILE A   6
ILE A  92
None
0.75A 5kr1A-1jflA:
undetectable
5kr1A-1jflA:
19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jg3 PROTEIN-L-ISOASPARTA
TE
O-METHYLTRANSFERASE


(Pyrococcus
furiosus)
PF01135
(PCMT)
5 LEU A 175
ASP A 160
ILE A 145
VAL A 164
ILE A 162
None
None
CL  A 300 ( 4.7A)
None
None
1.06A 5kr1A-1jg3A:
undetectable
5kr1A-1jg3A:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kcz BETA-METHYLASPARTASE

(Clostridium
tetanomorphum)
PF05034
(MAAL_N)
PF07476
(MAAL_C)
5 ARG A 298
ALA A 287
GLY A 244
ILE A 243
ILE A 251
None
0.92A 5kr1A-1kczA:
undetectable
5kr1A-1kczA:
14.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lk5 D-RIBOSE-5-PHOSPHATE
ISOMERASE


(Pyrococcus
horikoshii)
PF06026
(Rib_5-P_isom_A)
5 LEU A 161
ALA A 147
ILE A 200
GLY A 202
ILE A 141
None
1.06A 5kr1A-1lk5A:
undetectable
5kr1A-1lk5A:
22.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lvw GLUCOSE-1-PHOSPHATE
THYMIDYLYLTRANSFERAS
E


(Methanothermobacter
thermautotrophicus)
PF00483
(NTP_transferase)
5 ARG A  78
LEU A  50
ILE A 197
GLY A  85
ILE A   4
None
None
None
TYD  A3001 (-3.5A)
None
1.04A 5kr1A-1lvwA:
undetectable
5kr1A-1lvwA:
15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1m64 FLAVOCYTOCHROME C3

(Shewanella
frigidimarina)
PF00890
(FAD_binding_2)
PF14537
(Cytochrom_c3_2)
5 ALA A 516
GLY A 533
ILE A 553
VAL A 131
ILE A 310
None
FAD  A3000 (-3.4A)
FAD  A3000 (-3.6A)
None
None
1.05A 5kr1A-1m64A:
undetectable
5kr1A-1m64A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1m9s INTERNALIN B

(Listeria
monocytogenes)
PF08191
(LRR_adjacent)
PF09479
(Flg_new)
PF12354
(Internalin_N)
PF12799
(LRR_4)
PF13457
(SH3_8)
5 LEU A 110
ASN A 108
ILE A  82
VAL A  91
ILE A  88
None
1.03A 5kr1A-1m9sA:
undetectable
5kr1A-1m9sA:
10.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1oed ACETYLCHOLINE
RECEPTOR PROTEIN,
BETA CHAIN


(Torpedo
marmorata)
PF02932
(Neur_chan_memb)
5 LEU B 218
ILE B 287
ILE B 454
VAL B 222
ILE B 221
None
1.00A 5kr1A-1oedB:
undetectable
5kr1A-1oedB:
14.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1oi7 SUCCINYL-COA
SYNTHETASE ALPHA
CHAIN


(Thermus
thermophilus)
PF00549
(Ligase_CoA)
PF02629
(CoA_binding)
5 ALA A 107
ASP A 103
ILE A  99
GLY A 120
ILE A 119
None
1.06A 5kr1A-1oi7A:
undetectable
5kr1A-1oi7A:
16.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ALA A  28
ASP A  30
GLY A  49
ILE A  50
None
0.96A 5kr1A-1sivA:
18.2
5kr1A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
0.69A 5kr1A-1sivA:
18.2
5kr1A-1sivA:
50.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vlp NICOTINATE
PHOSPHORIBOSYLTRANSF
ERASE


(Saccharomyces
cerevisiae)
PF04095
(NAPRTase)
5 LEU A 330
ILE A 195
GLY A 212
ILE A 227
ILE A 353
None
1.06A 5kr1A-1vlpA:
undetectable
5kr1A-1vlpA:
12.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wn1 DIPEPTIDASE

(Pyrococcus
horikoshii)
PF00557
(Peptidase_M24)
PF01321
(Creatinase_N)
5 LEU A 167
ILE A 182
GLY A 217
ILE A 227
VAL A 188
None
1.05A 5kr1A-1wn1A:
undetectable
5kr1A-1wn1A:
14.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ydx TYPE I RESTRICTION
ENZYME SPECIFICITY
PROTEIN MG438


(Mycoplasma
genitalium)
PF01420
(Methylase_S)
5 ASN A 284
ILE A 204
GLY A 207
VAL A 289
ILE A 287
None
1.03A 5kr1A-1ydxA:
undetectable
5kr1A-1ydxA:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dnc PYRUVATE
DEHYDROGENASE
PROTEIN X COMPONENT


(Homo sapiens)
PF00364
(Biotin_lipoyl)
5 ALA A  55
ASP A  57
ILE A   8
GLY A  80
ILE A  64
None
1.00A 5kr1A-2dncA:
undetectable
5kr1A-2dncA:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ehh DIHYDRODIPICOLINATE
SYNTHASE


(Aquifex
aeolicus)
PF00701
(DHDPS)
5 ALA A  96
ASP A  97
ILE A  73
GLY A  75
ILE A 127
None
0.99A 5kr1A-2ehhA:
undetectable
5kr1A-2ehhA:
15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f2b AQUAPORIN AQPM

(Methanothermobacter
marburgensis)
PF00230
(MIP)
5 LEU A 157
ALA A 175
GLY A  74
VAL A  85
ILE A 161
GOL  A 501 (-4.8A)
None
None
GOL  A 501 (-4.9A)
None
1.02A 5kr1A-2f2bA:
undetectable
5kr1A-2f2bA:
16.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
5 LEU A  23
ILE A  53
GLY A  55
VAL A  87
ILE A  89
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.55A 5kr1A-2fmbA:
14.7
5kr1A-2fmbA:
33.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jls SERINE PROTEASE
SUBUNIT NS3


(Dengue virus)
PF07652
(Flavi_DEAD)
5 LEU A 204
ASP A 179
ILE A 281
VAL A 208
ILE A 207
None
1.04A 5kr1A-2jlsA:
undetectable
5kr1A-2jlsA:
14.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nr7 SECRETION ACTIVATOR
PROTEIN, PUTATIVE


(Porphyromonas
gingivalis)
PF05838
(Glyco_hydro_108)
PF09374
(PG_binding_3)
5 LEU A 134
ALA A 141
ILE A 103
VAL A  87
ILE A 138
None
1.03A 5kr1A-2nr7A:
undetectable
5kr1A-2nr7A:
22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qlp DEOXYCYTIDINE
TRIPHOSPHATE
DEAMINASE


(Mycobacterium
tuberculosis)
PF00692
(dUTPase)
5 LEU A  74
ASN A 132
ALA A 134
GLY A 105
ILE A 138
None
1.07A 5kr1A-2qlpA:
undetectable
5kr1A-2qlpA:
22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rd5 ACETYLGLUTAMATE
KINASE-LIKE PROTEIN


(Arabidopsis
thaliana)
PF00696
(AA_kinase)
5 LEU A 263
ILE A 231
GLY A 292
ILE A 273
ILE A 295
None
None
ARG  A1000 (-4.4A)
None
None
1.05A 5kr1A-2rd5A:
undetectable
5kr1A-2rd5A:
18.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ALA A  28
ASP A  30
GLY A  49
ILE A  50
AB1  A 501 ( 4.7A)
None
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
1.03A 5kr1A-2rkfA:
20.4
5kr1A-2rkfA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 ( 4.2A)
0.76A 5kr1A-2rkfA:
20.4
5kr1A-2rkfA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wae PENICILLIN-BINDING
PROTEIN 2B


(Streptococcus
pneumoniae)
PF00905
(Transpeptidase)
PF03717
(PBP_dimer)
5 ARG A  60
ASP A  65
GLY A 549
ILE A 550
ILE A  63
None
1.04A 5kr1A-2waeA:
undetectable
5kr1A-2waeA:
10.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zj8 PUTATIVE SKI2-TYPE
HELICASE


(Pyrococcus
furiosus)
PF00270
(DEAD)
PF00271
(Helicase_C)
PF14520
(HHH_5)
5 LEU A 681
ALA A 661
GLY A 655
VAL A 692
ILE A 687
None
1.03A 5kr1A-2zj8A:
undetectable
5kr1A-2zj8A:
10.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ep1 PGRP-HD -
PEPTIDOGLYCAN
RECOGNITION PROTEIN
HOMOLOGUE


(Alvinella
pompejana)
PF01510
(Amidase_2)
6 LEU A 104
ALA A 222
ASP A 100
ILE A 210
VAL A 186
ILE A 102
None
1.35A 5kr1A-3ep1A:
undetectable
5kr1A-3ep1A:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3euj CHROMOSOME PARTITION
PROTEIN MUKB, LINKER


([Haemophilus]
ducreyi)
PF04310
(MukB)
PF13558
(SbcCD_C)
5 LEU A1290
GLY A1396
ILE A1399
VAL A1301
ILE A1293
None
1.01A 5kr1A-3eujA:
undetectable
5kr1A-3eujA:
11.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f4n PYRIDOXINE
5'-PHOSPHATE
SYNTHASE


(Yersinia pestis)
PF03740
(PdxJ)
5 LEU A  61
ASP A  40
ILE A 219
VAL A  44
ILE A  42
None
1.06A 5kr1A-3f4nA:
undetectable
5kr1A-3f4nA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fd0 PUTATIVE
CYSTATHIONINE
BETA-LYASE INVOLVED
IN ALUMINUM
RESISTANCE


(Listeria
innocua)
PF06838
(Met_gamma_lyase)
5 LEU A 114
GLY A  95
ILE A  96
VAL A 118
ILE A 117
None
0.89A 5kr1A-3fd0A:
undetectable
5kr1A-3fd0A:
12.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jx8 PUTATIVE LIPOPROTEIN

(Parabacteroides
distasonis)
PF10988
(DUF2807)
5 LEU A 177
ASP A 213
ILE A 170
VAL A 155
ILE A 175
None
1.03A 5kr1A-3jx8A:
undetectable
5kr1A-3jx8A:
17.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jzl PUTATIVE
CYSTATHIONINE
BETA-LYASE INVOLVED
IN ALUMINUM
RESISTANCE


(Listeria
monocytogenes)
PF06838
(Met_gamma_lyase)
5 LEU A 114
GLY A  95
ILE A  96
VAL A 118
ILE A 117
None
0.85A 5kr1A-3jzlA:
undetectable
5kr1A-3jzlA:
14.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k2n SIGMA-54-DEPENDENT
TRANSCRIPTIONAL
REGULATOR


(Chlorobaculum
tepidum)
PF13185
(GAF_2)
5 LEU A 150
ALA A 158
GLY A 130
ILE A  41
VAL A  86
None
1.01A 5kr1A-3k2nA:
undetectable
5kr1A-3k2nA:
17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kvy URIDINE
PHOSPHORYLASE


(Bos taurus)
PF01048
(PNP_UDP_1)
5 LEU A 118
ALA A 250
GLY A 139
ILE A 138
ILE A 114
None
None
SO4  A 311 (-3.5A)
None
None
1.03A 5kr1A-3kvyA:
undetectable
5kr1A-3kvyA:
17.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kyj CHEY6 PROTEIN

(Rhodobacter
sphaeroides)
PF00072
(Response_reg)
5 LEU B  55
ALA B  77
ASP B  51
VAL B   8
ILE B  53
None
0.99A 5kr1A-3kyjB:
undetectable
5kr1A-3kyjB:
23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l8h PUTATIVE HALOACID
DEHALOGENASE-LIKE
HYDROLASE


(Bordetella
bronchiseptica)
PF13242
(Hydrolase_like)
5 LEU A   3
ALA A  49
ASP A   7
VAL A 121
ILE A   5
None
None
PO4  A2001 ( 2.8A)
None
None
0.92A 5kr1A-3l8hA:
undetectable
5kr1A-3l8hA:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lua RESPONSE REGULATOR
RECEIVER PROTEIN


(Ruminiclostridium
thermocellum)
PF00072
(Response_reg)
5 LEU A  51
ALA A  85
ASP A  55
VAL A   5
ILE A  53
None
1.02A 5kr1A-3luaA:
undetectable
5kr1A-3luaA:
24.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3maj DNA PROCESSING CHAIN
A


(Rhodopseudomonas
palustris)
PF02481
(DNA_processg_A)
5 ARG A  20
LEU A 110
ALA A 107
GLY A 350
ILE A 346
None
1.07A 5kr1A-3majA:
undetectable
5kr1A-3majA:
14.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
VAL A  82
ILE A  84
None
0.69A 5kr1A-3mwsA:
19.4
5kr1A-3mwsA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
LEU A  23
ASP A  30
ILE A  47
GLY A  49
ILE A  50
VAL A  82
ILE A  84
None
0.37A 5kr1A-3mwsA:
19.4
5kr1A-3mwsA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ILE A  54
GLY A  49
ILE A  50
ILE A  84
None
1.46A 5kr1A-3mwsA:
19.4
5kr1A-3mwsA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o8l 6-PHOSPHOFRUCTOKINAS
E, MUSCLE TYPE


(Oryctolagus
cuniculus)
PF00365
(PFK)
5 LEU A 711
ALA A 676
ILE A 425
VAL A 523
ILE A 525
None
0.82A 5kr1A-3o8lA:
undetectable
5kr1A-3o8lA:
9.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ors N5-CARBOXYAMINOIMIDA
ZOLE RIBONUCLEOTIDE
MUTASE


(Staphylococcus
aureus)
PF00731
(AIRC)
5 ALA A  67
ILE A  86
GLY A  93
ILE A  94
ILE A 100
None
1.03A 5kr1A-3orsA:
undetectable
5kr1A-3orsA:
20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3puo DIHYDRODIPICOLINATE
SYNTHASE


(Pseudomonas
aeruginosa)
PF00701
(DHDPS)
5 ALA A  97
ASP A  98
ILE A  74
GLY A  76
ILE A 128
None
1.03A 5kr1A-3puoA:
undetectable
5kr1A-3puoA:
15.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r11 ENZYME OF ENOLASE
SUPERFAMILY


(Francisella
philomiragia)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 ALA A  52
ASP A  32
GLY A  63
ILE A  67
VAL A  36
None
0.96A 5kr1A-3r11A:
undetectable
5kr1A-3r11A:
14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rh9 SUCCINATE-SEMIALDEHY
DE DEHYDROGENASE
(NAD(P)(+))


(Marinobacter
hydrocarbonoclasticus)
PF00171
(Aldedh)
5 LEU A 308
ASP A 326
ILE A 327
GLY A 285
VAL A 372
None
0.92A 5kr1A-3rh9A:
undetectable
5kr1A-3rh9A:
12.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ARG A   8
LEU A  23
ILE A  47
GLY A  49
ILE A  50
SO4  A 101 (-3.8A)
SO4  A 101 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.75A 5kr1A-3t3cA:
18.1
5kr1A-3t3cA:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ALA A  28
ILE A  47
GLY A  49
ILE A  50
SO4  A 101 (-4.2A)
017  A 201 (-3.5A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.94A 5kr1A-3t3cA:
18.1
5kr1A-3t3cA:
73.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tfw PUTATIVE
O-METHYLTRANSFERASE


(Klebsiella
pneumoniae)
PF01596
(Methyltransf_3)
5 LEU A  17
ASN A  48
ALA A  46
GLY A 213
VAL A  13
None
1.04A 5kr1A-3tfwA:
undetectable
5kr1A-3tfwA:
16.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ASP A  30
GLY A  49
ILE A  50
ILE A  84
017  A 201 ( 4.8A)
None
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.7A)
0.54A 5kr1A-3ttpA:
19.1
5kr1A-3ttpA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ARG A   8
LEU A  23
ALA A  28
ASP A  30
ILE A  47
None
None
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
0.90A 5kr1A-3u7sA:
19.5
5kr1A-3u7sA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ALA A  28
ILE A  47
GLY A  49
ILE A  50
None
None
017  A 201 (-3.4A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
0.97A 5kr1A-3u7sA:
19.5
5kr1A-3u7sA:
74.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w0s HYGROMYCIN-B
4-O-KINASE


(Escherichia
coli)
PF01636
(APH)
5 ALA A 118
GLY A 200
ILE A 232
VAL A 195
ILE A 122
None
1.06A 5kr1A-3w0sA:
undetectable
5kr1A-3w0sA:
12.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a9a RIBOSOME-INTERACTING
GTPASE 1


(Saccharomyces
cerevisiae)
PF01926
(MMR_HSR1)
PF02824
(TGS)
PF16897
(MMR_HSR1_Xtn)
5 LEU A 145
ILE A 122
GLY A  72
ILE A 149
VAL A  68
None
0.80A 5kr1A-4a9aA:
undetectable
5kr1A-4a9aA:
14.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fmz INTERNALIN

(Listeria
monocytogenes)
PF12354
(Internalin_N)
PF12799
(LRR_4)
PF13855
(LRR_8)
5 LEU A 343
ILE A 356
ILE A 310
VAL A 339
ILE A 340
None
EDO  A 405 (-3.8A)
None
None
None
0.95A 5kr1A-4fmzA:
undetectable
5kr1A-4fmzA:
18.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4if2 PHOSPHOTRIESTERASE
HOMOLOGY PROTEIN


(Mycobacterium
tuberculosis)
PF02126
(PTE)
5 ARG A 159
ALA A 147
ASP A 149
GLY A  72
ILE A  71
None
0.92A 5kr1A-4if2A:
undetectable
5kr1A-4if2A:
15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lik DNA PRIMASE SMALL
SUBUNIT


(Homo sapiens)
PF01896
(DNA_primase_S)
5 LEU A 336
GLY A 164
ILE A 110
VAL A 339
ILE A 334
None
0.95A 5kr1A-4likA:
undetectable
5kr1A-4likA:
12.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mwt LYSOSOMAL PROTECTIVE
PROTEIN


(Homo sapiens)
PF00450
(Peptidase_S10)
5 LEU A  54
ALA A 160
ILE A 364
GLY A 173
ILE A 156
LEU  A  54 ( 0.6A)
ALA  A 160 ( 0.0A)
ILE  A 364 ( 0.7A)
GLY  A 173 ( 0.0A)
ILE  A 156 ( 0.7A)
1.06A 5kr1A-4mwtA:
undetectable
5kr1A-4mwtA:
13.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nes UDP-N-ACETYLGLUCOSAM
INE 2-EPIMERASE


(Methanocaldococcus
jannaschii)
PF02350
(Epimerase_2)
6 LEU A  82
ALA A 101
ILE A  62
GLY A   8
VAL A  81
ILE A  78
None
1.30A 5kr1A-4nesA:
undetectable
5kr1A-4nesA:
15.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
None
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
0.71A 5kr1A-4njvA:
20.2
5kr1A-4njvA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
None
RIT  A 500 (-4.8A)
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-4.3A)
0.45A 5kr1A-4njvA:
20.2
5kr1A-4njvA:
83.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4okd ISOAMYLASE

(Chlamydomonas
reinhardtii)
PF00128
(Alpha-amylase)
PF02922
(CBM_48)
5 LEU A 682
ALA A 743
ASP A 754
GLY A 784
VAL A 788
None
0.95A 5kr1A-4okdA:
undetectable
5kr1A-4okdA:
8.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tnb G PROTEIN-COUPLED
RECEPTOR KINASE 5


(Homo sapiens)
PF00069
(Pkinase)
PF00615
(RGS)
5 LEU A  45
ASP A  52
GLY A  63
ILE A  62
ILE A  49
None
1.01A 5kr1A-4tnbA:
undetectable
5kr1A-4tnbA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4twb RIBOSE-PHOSPHATE
PYROPHOSPHOKINASE


(Sulfolobus
solfataricus)
PF00156
(Pribosyltran)
PF13793
(Pribosyltran_N)
5 ASP A 217
ILE A 245
GLY A 267
ILE A 279
ILE A 215
None
0.99A 5kr1A-4twbA:
undetectable
5kr1A-4twbA:
16.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4w5j ADENYLATE KINASE

(Streptococcus
pneumoniae)
PF00406
(ADK)
5 ARG A 124
LEU A 121
ILE A 179
ILE A   5
VAL A 116
AP5  A 302 (-3.5A)
None
None
None
None
0.99A 5kr1A-4w5jA:
undetectable
5kr1A-4w5jA:
18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yhj G PROTEIN-COUPLED
RECEPTOR KINASE 4


(Homo sapiens)
PF00069
(Pkinase)
PF00615
(RGS)
5 LEU A  45
ASP A  52
GLY A  63
ILE A  62
ILE A  49
None
1.06A 5kr1A-4yhjA:
undetectable
5kr1A-4yhjA:
10.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ypo KETOL-ACID
REDUCTOISOMERASE


(Mycobacterium
tuberculosis)
PF01450
(IlvC)
PF07991
(IlvN)
5 LEU A 161
ALA A   7
ASP A   6
GLY A 171
ILE A 169
None
0.97A 5kr1A-4ypoA:
undetectable
5kr1A-4ypoA:
14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywl CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF14551
(MCM_N)
PF17207
(MCM_OB)
5 ILE A 187
GLY A 205
ILE A 206
VAL A 214
ILE A 249
None
0.88A 5kr1A-4ywlA:
undetectable
5kr1A-4ywlA:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bn4 V-TYPE ATP SYNTHASE
ALPHA CHAIN


(Nanoarchaeum
equitans)
PF00006
(ATP-synt_ab)
PF02874
(ATP-synt_ab_N)
PF16886
(ATP-synt_ab_Xtn)
5 ARG A 188
LEU A  71
ILE A 168
GLY A 133
ILE A 131
None
1.00A 5kr1A-5bn4A:
undetectable
5kr1A-5bn4A:
13.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bwi GLYCOSIDE HYDROLASE
FAMILY 79


(Burkholderia
pseudomallei)
PF12891
(Glyco_hydro_44)
5 ALA A 330
ASP A 444
ILE A 324
VAL A 364
ILE A 362
None
1.05A 5kr1A-5bwiA:
undetectable
5kr1A-5bwiA:
13.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d01 N-ACETYL-ALPHA-D-GLU
COSAMINYL L-MALATE
SYNTHASE


(Bacillus
subtilis)
PF00534
(Glycos_transf_1)
PF13439
(Glyco_transf_4)
5 ALA A  93
ILE A  79
GLY A   7
ILE A   6
ILE A 116
None
1.06A 5kr1A-5d01A:
undetectable
5kr1A-5d01A:
14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dh2 SIDEROPHORE
PERIPLASMIC BINDING
PROTEIN


(Thermobifida
fusca)
PF01497
(Peripla_BP_2)
5 ASP A 177
ILE A 174
ILE A 160
VAL A 139
ILE A 151
None
0.92A 5kr1A-5dh2A:
undetectable
5kr1A-5dh2A:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hlb PENICILLIN-BINDING
PROTEIN 1B


(Escherichia
coli)
PF00905
(Transpeptidase)
PF00912
(Transgly)
PF14814
(UB2H)
5 LEU A 637
ALA A 658
GLY A 631
ILE A 628
VAL A 477
None
1.03A 5kr1A-5hlbA:
undetectable
5kr1A-5hlbA:
8.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5k97 FLAP ENDONUCLEASE 1

(Homo sapiens)
PF00752
(XPG_N)
PF00867
(XPG_I)
5 ALA A 246
ASP A 248
GLY A 240
VAL A 260
ILE A 259
None
1.04A 5kr1A-5k97A:
undetectable
5kr1A-5k97A:
14.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mz9 -

(-)
no annotation 5 ALA A 303
GLY A 387
ILE A 385
VAL A 547
ILE A 395
None
0.98A 5kr1A-5mz9A:
undetectable
5kr1A-5mz9A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n8p S-LAYER PROTEIN

(Caulobacter
vibrioides)
PF00353
(HemolysinCabind)
5 LEU A1007
ASP A 896
ILE A 880
ILE A 906
ILE A 921
None
CA  A9014 (-2.3A)
None
None
None
1.07A 5kr1A-5n8pA:
undetectable
5kr1A-5n8pA:
6.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n97 S-LAYER PROTEIN RSAA

(Caulobacter
vibrioides)
PF00353
(HemolysinCabind)
5 LEU A1007
ASP A 896
ILE A 880
ILE A 906
ILE A 921
None
CA  A9014 (-2.3A)
None
None
None
1.07A 5kr1A-5n97A:
undetectable
5kr1A-5n97A:
7.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5oyn DEHYDRATASE,
ILVD/EDD FAMILY


(Caulobacter
vibrioides)
no annotation 5 ALA A 249
ASP A 120
ILE A 144
ILE A 258
ILE A 245
None
0.93A 5kr1A-5oynA:
undetectable
5kr1A-5oynA:
20.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
None
0.82A 5kr1A-5t2zA:
19.6
5kr1A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
None
0.46A 5kr1A-5t2zA:
19.6
5kr1A-5t2zA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u4h UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE


(Acinetobacter
baumannii)
PF00275
(EPSP_synthase)
5 LEU A 382
ALA A 244
ILE A 311
GLY A 237
VAL A 378
None
0.98A 5kr1A-5u4hA:
undetectable
5kr1A-5u4hA:
15.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ubk ACYL-HOMOSERINE
LACTONE ACYLASE PVDQ


(Pseudomonas
aeruginosa)
PF01804
(Penicil_amidase)
5 LEU A  37
ALA A 586
ILE A 544
GLY A 659
ILE A 571
None
0.97A 5kr1A-5ubkA:
undetectable
5kr1A-5ubkA:
10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uze INOSINE-5'-MONOPHOSP
HATE
DEHYDROGENASE,INOSIN
E-5'-MONOPHOSPHATE
DEHYDROGENASE


(Clostridium
perfringens)
PF00478
(IMPDH)
5 LEU A 329
ALA A 290
ILE A 272
GLY A 274
ILE A 331
None
0.96A 5kr1A-5uzeA:
undetectable
5kr1A-5uzeA:
15.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x09 V-TYPE ATP SYNTHASE
ALPHA CHAIN,V-TYPE
ATP SYNTHASE ALPHA
CHAIN


(Pyrococcus
horikoshii)
no annotation 5 ARG A 199
LEU A  76
ILE A 174
GLY A 137
ILE A 135
None
1.03A 5kr1A-5x09A:
undetectable
5kr1A-5x09A:
11.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6acd -

(-)
no annotation 5 ALA A 676
ILE A 674
GLY A 638
ILE A 637
ILE A 652
None
1.03A 5kr1A-6acdA:
undetectable
5kr1A-6acdA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cfw MONOVALENT CATION/H+
ANTIPORTER SUBUNIT B


(Pyrococcus
furiosus)
no annotation 5 LEU F 133
ALA F  48
GLY F  24
ILE F  27
VAL F 129
None
1.02A 5kr1A-6cfwF:
undetectable
5kr1A-6cfwF:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eki CARBONIC ANHYDRASE

(Persephonella
marina)
no annotation 5 ARG A 247
ILE A 152
GLY A 150
VAL A  63
ILE A  65
None
0.99A 5kr1A-6ekiA:
undetectable
5kr1A-6ekiA:
23.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ALA A  28
ASP A  30
GLY A  49
ILE A  84
None
None
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
0.91A 5kr1A-6upjA:
17.6
5kr1A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 ARG A   8
LEU A  23
GLY A  49
ILE A  50
ILE A  84
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.97A 5kr1A-6upjA:
17.6
5kr1A-6upjA:
47.47